RSS

IPIX Innovation Pharmaceuticals Inc

Last Post: 10/20/26
Followers: 278
Posts Today: 0
Views Today: 465

IPIX Stock Quote & Tools

$0.0006 ▲ +0.0001 (+20.00%) As of Oct 23, 1:15 PM EDT
Last0.0006
$ Chg0.0001
Open0.0006
High0.0006
Beta140.0971
Year High0.050
Market Cap311.0K
P/B Ratio0.09
EPS-0.01
Avg Vol (30d)159.3K
Volume1.08M
% Chg+20.00%
Prev Close0.0005
Low0.0005
VWAP0.00051
Year Low0.000
Total Shares518.35M
Shares Out514.01M
Float391.87M
ExchangeOTCID
Healthcare Biotechnology & Life Sciences

IPIX Stock Message Board Discussion

  1. Lemoncat
  2. smokenhot
  3. scgmck1

Top 10 Most Recent News Articles

TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 191

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 214

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Aluminum Design Fumble: Geometry Over Wall Thickness

Updated Category News Views 135

A Misstep in Aluminum Design Practices Well, here's a nugget of wisdom for the metal enthusiasts out there—stop beefing up aluminum components with thicker walls and focus on smart geometry. This isn't a drill, folks. Mark Coyle, a seasoned mind over at American Custom Metals, has been waving the flag for smarter aluminum design methods right from Rochester, NY, and...

Continue Reading
Lilly's Sofe-M Shakes Up Ovarian Cancer Treatment

Updated Category News Views 295

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Continue Reading
Axon Body 5: A Leap Forward in AI for Public Safety

Updated Category News Views 270

Axon Raises the Stakes with Body 5 Camera Boy, oh boy, Axon's dropped a bombshell with the Body 5. We're talking a colossal leap into the AI era for public safety, and if you're in the biz, you can't just shrug this one off. We're looking at 25 times the AI processing power compared to Axon's old units. That's right, I said twenty-five. Real-time situational awareness in...

Continue Reading
DigitalXForce Booms with 514% Growth and Major Backing

Updated Category News Views 282

Massive Growth and Strategic Investment in DigitalXForce Now here’s a company that’s shaking things up—DigitalXForce. Right on the back of a staggering 514% growth, they’ve corralled a strategic investment from Arsenal Growth Equity. If you blink, you might miss just how fast they’re sprinting through the tech landscape. Institutional Support Backing the...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 92

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 69

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 143

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 86

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

N3on and Iggy Azalea Elevate Online Gaming with MOTHERLAND

Updated Category News Views 459

N3on Partners with Iggy Azalea to Transform Online Gaming The partnership between N3on and Iggy Azalea marks an exciting evolution in the online gaming landscape, fusing pop culture with innovative technologies in the online casino space. This collaboration represents an incredible opportunity to reshape gaming entertainment by integrating a diverse array of experiences,...

Continue Reading
Quorum Information Technologies Set for Acquisition by Valsoft Corporation

Updated Category News Views 235

Quorum Information Technologies Reports Acquisition by Valsoft Quorum Information Technologies Inc. (TSX-V: QIS) has confirmed a definitive agreement for its acquisition by Valsoft Corporation, marking a strategic move for both companies. The all-cash transaction amounts to $0.80 for each outstanding common share of Quorum, a commendable offer that has been approved...

Continue Reading
New Funding Agreement to Support Bay Area Transit Systems

Updated Category News Views 250

Agreement Reached on Loan for Bay Area Transit Agencies In a significant development for the region, the Office of the Governor, the California Department of Finance, and the Metropolitan Transportation Commission (MTC) have announced a $590 million loan intended to support Bay Area transit agencies. This funding aims to prevent potential service cuts at critical transit...

Continue Reading
Uniti Group's Upcoming Presentation at the BofA Conference

Updated Category News Views 148

Uniti Group Inc. to Present at BofA Securities Conference Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) has recently announced an exciting opportunity for its leadership team to engage with investors during an upcoming financial conference. The company’s Senior Vice President, Chief Financial Officer, and Treasurer, Paul Bullington, along with Vice President of Investor...

Continue Reading
Fidelis Insurance Group Plans Fourth Quarter 2024 Results Release

Updated Category News Views 181

Fidelis Insurance Group's Upcoming Financial Results Announcement Fidelis Insurance Holdings Limited (NYSE:FIHL) is gearing up to share its financial performance for the fourth quarter that concluded in December 2024. This eagerly awaited release is scheduled for February 25, 2025, and will occur right after the financial markets conclude their daily functions. Investor...

Continue Reading